James Caruso
Tracked across 1 events · 6 articles · First seen Jul 30, 2026 · Last active Aug 13, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Cellectar Biosciences, a late-stage clinical biopharmaceutical company, announced its second quarter 2026 financial results and provided a corporate update on August 13, 2026. The company reported cash and cash equivalents of $34.0 million as of…
Impact: As CEO, James Caruso provided the corporate update and expressed confidence in the company's strategy and near-term catalysts.
Jul 30, 2026 · 6 articles
ERGEN INTELLIGENCE
Track James Caruso live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard